Global Neurotrophic Keratitis Market Report 2024, with Profiles of Dompe, Oyster Point Pharma, Neuroptica, Recordati Rare Diseases, KALA BIO, ReGenTree, BRIM Biotechnology, Oculis and HLB Therapeutics
May 14, 2024 08:57 ET
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Neurotrophic Keratitis Market Outlook 2023-2036" report has been added to ResearchAndMarkets.com's offering.The global neurotrophic keratitis...
Global $500+ Mn Neurotrophic Keratitis Markets, 2023-2028 - Rising Fungal Keratitis Cases Spur Demand for New Solutions
August 22, 2023 08:53 ET
|
Research and Markets
Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Neurotrophic Keratitis Market (2023-2028) by Route of Administration, Distribution Channel, and Geography, Competitive Analysis, Impact of...
Neurotrophic Keratitis Market Report Up to 2031: Visiongain Research Inc
December 13, 2021 09:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Neurotrophic Keratitis Market Report 2021-2031: Forecasts By Treatment (Drugs, Devices, and Surgical Intervention) By Stage (Stage I, Stage II, and Stage III),...